At Investor Conferences

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Organisation › Details

InnoRNA, Hong Kong Office

InnoRNA is a platform-based biotechnology company focused on developing innovative mRNA and LNP technologies to produce therapeutic proteins rapidly and accurately in cells. Faced with the challenge of delivering mRNA into the right cells, the existing carriers have been unable to maximize the potential of mRNA as a therapeutic tool to generate disease-fighting proteins. InnoRNA developed the proprietary Diversity-Oriented LNP platform to deliver mRNA safely and effectively into the cell of interest. The commercialization of this innovation presents a revolutionary step towards delivering effective and safe clinical mRNA treatments for societies everywhere. *

 

Period Start 2022-07-06 existent
  Group InnoRNA Biotechnology Co., Ltd.
Products Industry mRNA-based drug
  Industry 2 Diversity-Oriented LNP platform (InnoRNA)
     
Region Region Hong Kong
  Country China
  Street Rm 222, 12 W Science and Technology West Avenue, Phase 3
HKSTP, Shatin
  City n. a. Hong Kong
    Address record changed: 2022-07-16
     
Basic data Employees n. a.
     
    * Document for »About Section«: BeiGene, Ltd.. (7/6/22). "Press Release: BeiGene Announces Strategic Research Collaboration with InnoRNA to Jointly Discover Novel mRNA Therapies". Cambridge, MA, Basel & Beijing.
     
   
Record changed: 2023-07-10

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for InnoRNA Biotechnology Co., Ltd.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x300px




» top